Is host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G an innate defensive factor and drug target against hepatitis C virus?
hA3G appears to be a cellular restrict factor against HCV and could be a potential target for drug discovery.
These studies indicate that dual EGFR/HER2 inhibition, administered together with AWT, sensitize prostate cancer cells to apoptosis during AWT.